PRAC
What does it mean in plain English?
PRAC stands for the Pharmacovigilance Risk Assessment Committee: the group inside the European Medicines Agency (EMA) responsible for reviewing and assessing safety signals for medicines used across the EU. When a potential new risk is flagged, whether through disproportionality analysis, a spike in adverse event reports, or a new study, PRAC is the body that actually evaluates it.
After reviewing the evidence, PRAC issues recommendations: anything from updating a medicine's label, to adding a new Black Triangle, to requiring an additional safety study, to, in serious cases, suspending a product entirely. Those recommendations then move on to other EMA committees or national authorities to be formally adopted.
Who's actually in the room
PRAC isn't just EMA staff reviewing paperwork alone; it's a deliberately mixed panel. Hover each seat to see what it brings.
Hover a seat to see its roleNational Representatives
One expert nominated by every EU/EEA country's own medicines agency.
Independent Scientific Experts
Extra specialists appointed for deep expertise, not for representing a country.
Healthcare Professional
Brings the clinician's day-to-day view of how a safety issue actually plays out.
Patient Representative
Brings the lived experience of actually taking the medicine.
Common Misconceptions
"So PRAC basically IS the EMA? If they flag something as a risk, that's the final word, right?"
Not quite. PRAC is one specialized committee inside the EMA, focused specifically on safety. Its recommendations are influential but usually still need to be formally adopted by other committees, like the CHMP (Committee for Medicinal Products for Human Use), or by national authorities, before anything actually changes.
